Uridine triphosphate trisodium salt
(Synonyms: 尿苷-5'-三磷酸三钠盐) 目录号 : GC37867
A nucleotide and dual P2Y2 and P2Y4 receptor agonist
Cas No.:19817-92-6
Sample solution is provided at 25 µL, 10mM.
Uridine 5'-triphosphate (UTP) is a nucleotide and dual agonist of purinergic P2Y2 and P2Y4 receptors (EC50s = 55 and 80 nM, respectively, for stimulation of phospholipase C in 1321N1 cells expressing human receptors).1,2 It is selective for P2Y2 and P2Y4 receptors over P2Y6 receptors (EC50 = >10,000 nM).2 UTP stimulates proliferation of PANC-1 cells (EC50 = 13.1 μM), an effect that can be prevented by siRNA against the P2Y2 receptor.1 It induces vasoconstriction in perfused isolated canine epicardial coronary artery in a concentration-dependent manner.3 UTP is formed from uridine monophosphate (UMP) by two sequential phosphorylations and can be converted to cytidine 5'-triphosphate .4 It also reacts with glucose-1-phosphate to form UDP-glucose , a precursor in the biosynthesis of glycogen.5
1.Choi, J.H., Ji, Y.G., and Lee, D.H.Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptorPancreas42(4)680-686(2013) 2.Maruoka, H., Jayasekara, M.P.S., Barrett, M.O., et al.Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y4 receptorJ. Med. Chem.54(12)4018-4033(2011) 3.Matsumoto, T., Nakane, T., and Chiba, S.UTP induces vascular responses in the isolated and perfused canine epicardial coronary artery via UTP-preferring P2Y receptorsBr. J. Pharmacol.122(8)1625-1632(1997) 4.Berg, J.M., Tymoczko, J.L., and Stryer, L.In de novo synthesis, the pyrimidine ring is assembled from bicarbonate, aspartate, and glutamineBiochemistry(2002) 5.Berg, J.M., Tymoczko, J.L., and Stryer, L.Glycogen is synthesized and degraded by different pathwaysBiochemistry(2002)
| Cas No. | 19817-92-6 | SDF | |
| 别名 | 尿苷-5'-三磷酸三钠盐 | ||
| Canonical SMILES | O[C@H]1[C@H](N2C(NC(C=C2)=O)=O)O[C@H](COP(OP(OP(O[Na])(O[Na])=O)(O[Na])=O)(O)=O)[C@H]1O | ||
| 分子式 | C9H12N2Na3O15P3 | 分子量 | 550.09 |
| 溶解度 | Water: 110 mg/mL (199.97 mM); DMSO: < 1 mg/mL (insoluble or slightly soluble) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.8179 mL | 9.0894 mL | 18.1788 mL |
| 5 mM | 363.6 μL | 1.8179 mL | 3.6358 mL |
| 10 mM | 181.8 μL | 908.9 μL | 1.8179 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















